IBI-A-6a Accepted in Part

Financial Loss and Care

Infected Blood Inquiry · Additional Report on Compensation · Issued 9 July 2025 · Addressed to: UK Government

Source — verbatim from the inquiry

Inquiry recommendation

"x" be removed from the equation set out in Regulation 7.

Infected Blood Inquiry, Additional Report on Compensation · 9 Jul 2025 Source PDF →

Published evidence summary

Publicly available evidence relating to this recommendation:

- The Government stated in July 2025 that it accepted this recommendation in principle and recognised the need for change regarding past care and financial loss calculations, but would consult on appropriate adjustments (Infected Blood Inquiry Additional Report: Government Response, Cabinet Office, July 2025).
- A consultation on proposed changes to the infected blood compensation scheme was opened on 24 November 2025 (Consultation: Proposed Changes to the Infected Blood Compensation Scheme, Cabinet Office, November 2025).

Response — verbatim from government

UK Government

The Inquiry has raised concerns regarding the calculation of past care and financial loss awards for those who choose to continue receiving support scheme payments. The Inquiry has recommended that a formula in the regulations be changed to address its concerns. However, the Inquiry's recommended change would only change the calculation of past care, and not past financial loss. The Inquiry has recommended removing the 25% discount for living claimants who choose to receive support scheme payments. However removing the discount for this group only would lead to differences of treatment between the living and the deceased in respect of past care. The Government accepts the need for a change to the scheme in this area but for these reasons plans to consult on what would be the most appropriate set of changes to make.

UK Government · 21 Jul 2025 Written response →

Evidence trail — what's actually happened since

  • 21 Jul 2025 14 April 2026 update: Government response (CP 1565) introduces an Exceptional Loss uplift: "Following the consultation, we are introducing a compensation uplift of £60,000 for people who had entered, or had an offer to enter, a higher-earning career but were unable to progress in this career due to their infection. This award will be available through the supplementary route and will come in addition to Financial Loss awards paid through the core route. People will not need to show an actual salary offer or earnings, instead IBCA will determine whether a given career would have generally paid at least 10% higher than the gross national median average earnings. If so, a person would automatically be eligible for the £60,000 award." Regulations to implement these changes will be brought forward later in 2026. Sources: https://www.gov.uk/government/news/changes-to-infected-blood-compensation-scheme-will-improve-support-for-victims; https://assets.publishing.service.gov.uk/media/69ddf5fd7e2086c62da2f152/Government_response_to_consultation_on_proposed_changes_to_the_infected_blood_compensation_scheme__PDF_.pdf Source →
  • 15 Jan 2026 · IBCA Community Update As of 13 January 2026: 3,721 people asked to start claims, 3,546 begun process, 3,074 received offers totalling £2.47bn, 2,861 paid totalling £1.89bn. Third compensation regulations in force 31 December 2025. View source → Good Progress
  • 28 Oct 2025 · IBCA Independent Review IBCA has contacted 2,215 people to begin compensation claims; 1,934 started process. £812m+ paid via Horizon Shortfall Scheme. £11.8bn committed in Autumn Budget. View source → Reasonable Progress

Each entry above links to a primary source — gov.uk written statement, consultation response document, or inspection report. The Index does not characterise government intent; it tracks what has been published.

How this page is built

Source and Response are verbatim from primary documents. The Evidence trail records published activity since — written statements, consultation outcomes, inspection findings, parliamentary references. The Index does not paraphrase or characterise intent; it tracks what has been published. Where the evidence is the absence of action (a missed deadline, a slipped timetable), that absence is documented from primary sources rather than inferred.

This recommendation's data is verified periodically against primary sources. The Index is monitored for staleness weekly.